LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study / Bertagna, X., Pivonello, R., Fleseriu, M., Zhang, Y., Robinson, P., Taylor, A., Watson, C.e., Maldonado, M., Hamrahian, A.h., Boscaro, M., Biller, B.m.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 99:(2014). [10.1210/jc.2013-2117]

LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.

PIVONELLO, ROSARIO;
2014

2014
LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study / Bertagna, X., Pivonello, R., Fleseriu, M., Zhang, Y., Robinson, P., Taylor, A., Watson, C.e., Maldonado, M., Hamrahian, A.h., Boscaro, M., Biller, B.m.. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 99:(2014). [10.1210/jc.2013-2117]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/584797
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 188
  • ???jsp.display-item.citation.isi??? ND
social impact